Breaking News

ADMA Biologics Reports Updated Compliance Status

FDA inspection database confirms VAI status of Boca Raton, FL facility

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

ADMA Biologics, a commercial biopharmaceutical company that manufactures, markets and develops specialty plasma-based biologics for the prevention and treatment of certain infectious diseases, said that the FDA inspection database classification website has been updated and confirms ADMA’s compliance status has improved to Voluntary Action Indicated (VAI). “We are pleased that the FDA has acknowledged the improved current good manufacturing practice (cGMP) conditions at our manufa...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters